NutropinAq^® [ somatropin, recombinant DNA origin, Escherichia coli ]

Description

NutropinAq^® is a liquid formulation of a recombinant human growth hormone administered using the NutropinAq^® Pen.

Active substance

somatropin, recombinant DNA origin, Escherichia coli

NutropinAq^® is indicated for:

• Long-term treatment of children with growth failure due to inadequate endogenous growth hormone secretion.
• Long-term treatment of growth failure associated with Turner syndrome.
• Treatment of prepubertal children with growth failure associated with chronic renal insufficiency up to the time of renal transplantation.
• Replacement of endogenous growth hormone in adults with growth hormone deficiency of either childhood or adult-onset etiology. Growth hormone deficiency should be confirmed appropriately prior to treatment.

GO TO